JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
9 ! | Sun, 7/31/2011, 2:00 PM - 3:50 PM | CC-B210/211 | |
Including Disease Models and Biomarkers in the Statistical Design of Clinical Trials — Invited Papers | |||
Biopharmaceutical Section , International Indian Statistical Association , Section on Statistics in Epidemiology , Committee of Representatives to AAAS | |||
Organizer(s): Tom Parke, Tessella | |||
Chair(s): Tom Parke, Tessella | |||
2:05 PM | The Use of Drug Disease Models and Biomarkers in Trial Design — Brenda Gaydos, Eli Lilly and Company | ||
2:40 PM | Incorporating Biomarkers and Auxiliary Data in the Design of Adaptive Clinical Trials — Ashish Sanil, Berry Consultants ; Scott Berry, Berry Consultants | ||
3:15 PM | Discussant: Michael Krams, Johnson & Johnson Pharmaceutical R&D, LLC | ||
3:35 PM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.